Abstract
Exploring Triazole Derivatives as DPP IV Inhibitors: Advancing Type II Diabetes Treatment via Molecular Structure Investigation and Pharmacophore Modelling
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have